Global Statistics

All countries
343,270,696
Confirmed
Updated on January 21, 2022 5:35 am
All countries
274,213,020
Recovered
Updated on January 21, 2022 5:35 am
All countries
5,593,457
Deaths
Updated on January 21, 2022 5:35 am

Global Statistics

All countries
343,270,696
Confirmed
Updated on January 21, 2022 5:35 am
All countries
274,213,020
Recovered
Updated on January 21, 2022 5:35 am
All countries
5,593,457
Deaths
Updated on January 21, 2022 5:35 am

Has COVID-19 Led to More Advanced Cancers?

Months of lockdowns throughout 2020 brought mass cancer screening programs to a halt in the United States. Early in the COVID-19 pandemic, the American Cancer Society recommended that “no one should go to a health care facility for routine cancer screening.”

For example, from March to June 2020 at Massachusetts General Hospital in Boston, cancer screening fell by 60%-82% for five common screening tests: low-dose CT, Pap smear, colonoscopy, prostate-specific antigen testing, and mammography.

Oncologists and pathologists have wondered whether the pause in screening will ultimately leave patients with asymptomatic cancers or precursor lesions worse off.

Tell us whether restrictions on cancer screening over the last year have affected the clinical presentation of your patients.

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Hot Topics

Related Articles